Douglas Jones to Vascular Patency
This is a "connection" page, showing publications Douglas Jones has written about Vascular Patency.
Connection Strength
1.791
-
Creeden T, Jones DW. "Evolution of Drug-Coated Devices for the Treatment of Chronic Limb Threatening Ischemia". Ann Vasc Surg. 2024 Oct; 107:76-83.
Score: 0.854
-
Pike SL, Farber A, Arinze N, Levin S, Cheng TW, Jones DW, Tan TW, Malas M, Rybin D, Siracuse JJ. Patients with lower extremity dialysis access have poor primary patency and survival. J Vasc Surg. 2019 12; 70(6):1913-1918.
Score: 0.153
-
Siracuse JJ, Cheng TW, Arinze NV, Levin SR, Jones DW, Malas MB, Kalish JA, Rybin D, Farber A. Snuffbox arteriovenous fistulas have similar outcomes and patency as wrist arteriovenous fistulas. J Vasc Surg. 2019 Aug; 70(2):554-561.
Score: 0.150
-
Jones DW, Goodney PP, Eldrup-Jorgensen J, Schermerhorn ML, Siracuse JJ, Kang J, Columbo JA, Suckow BD, Stone DH. Active smoking in claudicants undergoing lower extremity bypass predicts decreased graft patency and worse overall survival. J Vasc Surg. 2018 09; 68(3):796-806.e1.
Score: 0.140
-
Jones DW, Graham A, Connolly PH, Schneider DB, Meltzer AJ. Restenosis and symptom recurrence after endovascular therapy for claudication: does duplex ultrasound correlate with recurrent claudication? Vascular. 2015 Feb; 23(1):47-54.
Score: 0.107
-
Diamond KR, Simons JP, Crawford AS, Arous EJ, Judelson DR, Aiello F, Jones DW, Messina L, Schanzer A. Effect of thoracoabdominal aortic aneurysm extent on outcomes in patients undergoing fenestrated/branched endovascular aneurysm repair. J Vasc Surg. 2021 09; 74(3):833-842.e2.
Score: 0.043
-
Arinze N, Ryan T, Pillai R, Vilvendhan R, Farber A, Jones DW, Rybin D, Levin SR, Cheng TW, Siracuse JJ. Perioperative and long-term outcomes after percutaneous thrombectomy of arteriovenous dialysis access grafts. J Vasc Surg. 2020 12; 72(6):2107-2112.
Score: 0.041
-
Dicken QG, Cheng TW, Farber A, Levin SR, Jones DW, Malas MB, Tan TW, Rybin D, Siracuse JJ. Patients with human immunodeficiency virus infection do not have inferior outcomes after dialysis access creation. J Vasc Surg. 2020 12; 72(6):2113-2119.
Score: 0.040
-
Farber A, Cheng TW, Nimmich A, Jones DW, Kalish JA, Eslami MH, Hardouin S, Siracuse JJ. Femoral vein transposition is a durable hemodialysis access for patients who have exhausted upper extremity options. J Vasc Surg. 2020 03; 71(3):929-936.
Score: 0.039
-
Hardouin S, Cheng TW, Farber A, Kalish JA, Jones DW, Malas MB, Rybin D, Oriel BS, Plauche LM, Siracuse JJ. Axillary-bifemoral and axillary-unifemoral artery grafts have similar perioperative outcomes and patency. J Vasc Surg. 2020 03; 71(3):862-868.
Score: 0.039
-
Levin SR, Farber A, Cheng TW, Arinze N, Jones DW, Kalish JA, Rybin D, Siracuse JJ. Risk assessment of significant upper extremity arteriovenous graft infection in the Vascular Quality Initiative. J Vasc Surg. 2020 03; 71(3):913-919.
Score: 0.039
-
Humbarger O, Siracuse JJ, Rybin D, Stone DH, Goodney PP, Schermerhorn ML, Farber A, Jones DW. Broad variation in prosthetic conduit use for femoral-popliteal bypass is not justified on the basis of contemporary outcomes favoring autologous great saphenous vein. J Vasc Surg. 2019 11; 70(5):1514-1523.e2.
Score: 0.038
-
Roberts L, Farber A, Jones DW, Woo K, Eslami MH, Simons J, Malas M, Tan TW, Rybin D, Siracuse JJ. Tapered arteriovenous grafts do not provide significant advantage over nontapered grafts in upper extremity dialysis access. J Vasc Surg. 2019 05; 69(5):1552-1558.
Score: 0.037
-
Raulli SJ, Cheng TW, Farber A, Eslami MH, Kalish JA, Jones DW, Rybin DV, Nuhn M, Gautam A, Siracuse JJ. Intraoperative Heparin Use during Upper Extremity Arteriovenous Access Creation Does Not Affect Outcomes. Ann Vasc Surg. 2019 Feb; 55:216-221.
Score: 0.036
-
Komshian S, Cheng TW, Farber A, Schermerhorn ML, Kalish JA, Rybin D, Jones DW, Siracuse JJ. Retrograde popliteal access to treat femoropopliteal artery occlusive disease. J Vasc Surg. 2018 07; 68(1):161-167.
Score: 0.035